A Rare Case of Plasmablastic Lymphoma in a Patient with HIV and SARS-CoV-2 Infections.
COVID-19
Epstein–Barr
HIV
non-Hodgkin’s lymphoma
oral manifestation
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
02 03 2022
02 03 2022
Historique:
received:
24
01
2022
revised:
21
02
2022
accepted:
28
02
2022
entrez:
24
3
2022
pubmed:
25
3
2022
medline:
31
3
2022
Statut:
epublish
Résumé
Lesions commonly associated with HIV infection include oral candidiasis, herpes simplex infection, oral Kaposi's sarcoma, hairy leukoplakia, periodontal diseases (linear gingival erythema and necrotizing ulcerative periodontitis), xerostomia, human papillomavirus-associated warts, aphthous ulcers, non-Hodgkin's lymphoma, histoplasmosis, carcinoma, exfoliative cheilitis, and HIV salivary gland disease. Non-Hodgkin's lymphoma (NHL) is the most common cancer in people living with HIV (PLWH), and the incidence is increased for aggressive B-cell NHL. Plasmablastic lymphoma (PbL) is a rare and aggressive B-cell malignancy that is often unresponsive to chemotherapy and usually has a poor prognosis. We hereby present the case of a patient with a recent history of COVID-19 infection who was diagnosed with HIV and NHL, with manifestations in the oral cavity and a favorable evolution after the introduction of antiviral therapy, specific chemotherapy, and radiotherapy. Dental expertise is necessary for the appropriate management of oral manifestations of HIV infection or AIDS, and lymphoma should be included in the differential diagnosis of any oral lesions.
Identifiants
pubmed: 35323329
pii: curroncol29030129
doi: 10.3390/curroncol29030129
pmc: PMC8947703
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
1537-1543Références
Biomed Pharmacother. 2001 Sep;55(7):348-52
pubmed: 11669495
Contemp Clin Dent. 2010 Jan;1(1):1-5
pubmed: 22114368
Salud Publica Mex. 2018 Nov-Dic;60(6):653-657
pubmed: 30699270
Rom J Morphol Embryol. 2021 Jan-Mar;62(1):63-71
pubmed: 34609409
Bull Cancer. 2021 Oct;108(10):953-962
pubmed: 34246454
Oral Dis. 2002;8 Suppl 2:80-7
pubmed: 12164666
Int Arch Otorhinolaryngol. 2014 Jul;18(3):260-5
pubmed: 25992103
Germs. 2019 Dec 2;9(4):198-210
pubmed: 32042727
Blood Lymphat Cancer. 2018 Oct 04;8:63-70
pubmed: 31360094
Clin Infect Dis. 2014 Jun;58(11):1599-606
pubmed: 24523217
Leuk Lymphoma. 2018 Jun;59(6):1375-1383
pubmed: 29019447
J Natl Compr Canc Netw. 2019 Feb;17(2):171-189
pubmed: 30787130
J Oral Pathol Med. 2016 Jan;45(1):3-8
pubmed: 25639844
Sci Rep. 2021 May 25;11(1):10902
pubmed: 34035353
Cancers (Basel). 2021 Nov 16;13(22):
pubmed: 34830876
Ann Oncol. 2017 Apr 1;28(4):843-848
pubmed: 28031174
Med Clin (Barc). 2018 Apr 23;150(8):291-296
pubmed: 28528797
Ecancermedicalscience. 2016 Aug 17;10:665
pubmed: 27594910
Curr Opin Oncol. 2021 Mar 1;33(2):149-158
pubmed: 33405482
Acta Biomed. 2020 Jul 13;91(3):ahead of print
pubmed: 32921739
Ther Adv Med Oncol. 2021 Apr 29;13:17588359211011455
pubmed: 33995596
Int J Dermatol. 2019 Oct;58(10):1165-1171
pubmed: 30927252
Br J Haematol. 2021 Feb;192(3):415
pubmed: 33386647
Curr HIV/AIDS Rep. 2008 Feb;5(1):5-12
pubmed: 18417029
Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2551-9
pubmed: 22109347